Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:CO
Previous Symbol
CUSIPN/A
Phone852-3605-8180
Debt
Debt-to-Equity RatioN/A
Current Ratio9.33
Quick Ratio9.27
Price-To-Earnings
Trailing P/E Ratio20.00
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$149.34 million
Price / Sales4.88
Cash Flow$0.3812 per share
Price / Cash Flow15.74
Book Value$4.12 per share
Price / Book1.46
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$37.79 million
Net Margins24.77%
Return on Equity7.53%
Return on Assets4.00%
Miscellaneous
Employees1,196
Outstanding Shares121,550,000
Market Cap$729.31 million
OptionableOptionable
Global Cord Blood (NYSE:CO) Frequently Asked Questions
What is Global Cord Blood's stock symbol?
Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
How often does Global Cord Blood pay dividends? What is the dividend yield for Global Cord Blood?
Global Cord Blood announced an annual dividend on Tuesday, June 26th. Stockholders of record on Monday, July 30th will be paid a dividend of $0.08 per share on Monday, August 20th. This represents a dividend yield of 0.93%. The ex-dividend date of this dividend is Friday, July 27th. View Global Cord Blood's Dividend History.
How were Global Cord Blood's earnings last quarter?
Global Cord Blood Corp (NYSE:CO) posted its quarterly earnings data on Tuesday, November, 27th. The medical research company reported $0.08 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.11 by $0.03. The medical research company earned $35.98 million during the quarter. Global Cord Blood had a return on equity of 7.53% and a net margin of 24.77%. View Global Cord Blood's Earnings History.
When is Global Cord Blood's next earnings date?
Has Global Cord Blood been receiving favorable news coverage?
Media headlines about CO stock have trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Global Cord Blood earned a news impact score of 1.0 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are some of Global Cord Blood's key competitors?
Some companies that are related to Global Cord Blood include Gs Acquisition Holdings Cl A (GSAH), Bain Capital Specialty Finance (BCSF), Vantage Energy Acquisition (VEAC), CHURCHILL CAP C/SH (CCC), Verra Mobility (VRRM), Alta Mesa Resources (AMR), HAYMAKER ACQUIS/SH CL A (HYAC), Pensare Acquisition (WRLS), Falcon Minerals (FLMN), GTY Technology (GTYH), Modern Media Acquisition (MMDM), Forum Merger Ii Cl A (FMCI), AgroFresh Solutions (AGFS), KBL MERGER CORP/SH (KBLM) and Jetpay (JTPY).
Who are Global Cord Blood's key executives?
Global Cord Blood's management team includes the folowing people:
- Ms. Ting Zheng, Chairman, CEO & Interim CEO of Beijing Division (Age 46)
- Mr. Albert Chen, CFO & Director (Age 42)
- Ms. Xin Xu, Chief Technology Officer (Age 64)
- Ms. Rui Arashiyama, Chief Exec. Officer of Guangdong Division & Zhejiang Division (Age 59)
- Ms. Cathy Bai, VP of Corp. Fin.
Who are Global Cord Blood's major shareholders?
Global Cord Blood's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.15%), Vanguard Group Inc (0.98%), Man Group plc (0.58%), PEAK6 Investments LLC (0.08%), Panagora Asset Management Inc. (0.03%) and PNC Financial Services Group Inc. (0.03%). View Institutional Ownership Trends for Global Cord Blood.
Which major investors are selling Global Cord Blood stock?
Which major investors are buying Global Cord Blood stock?
CO stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, PEAK6 Investments LLC, Panagora Asset Management Inc., PNC Financial Services Group Inc. and Vanguard Group Inc. View Insider Buying and Selling for Global Cord Blood.
How do I buy shares of Global Cord Blood?
Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Cord Blood's stock price today?
One share of CO stock can currently be purchased for approximately $6.00.
How big of a company is Global Cord Blood?
Global Cord Blood has a market capitalization of $729.31 million and generates $149.34 million in revenue each year. Global Cord Blood employs 1,196 workers across the globe.
What is Global Cord Blood's official website?
How can I contact Global Cord Blood?
Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]
MarketBeat Community Rating for Global Cord Blood (NYSE CO)
MarketBeat's community ratings are surveys of what our community members think about Global Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.
